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Background. Dynamic changes of myocardial blood flow have
been observed after reperfusion of an occluded coronary artery.
MCE performed by intracoronary contrast injection can provide
an estimate of microvascular flow. We hypothesized that MCE
performed using intravenous infusion of a new generation con-
trast agent and electrocardiogram-gated harmonic imaging would
be able to assess serial changes of microvascular perfusion.
Objective. To study the potential of myocardial contrast echo-
cardiography (MCE) to assess serial changes of microvascular
flow during ischemia-reperfusion.
Methods. Sixteen dogs underwent 90 or 180 min of left anterior
descending coronary occlusion, followed by 180 min of reperfu-
sion. Regional blood flow (RBF) was measured with fluorescent
microspheres at baseline, during coronary occlusion, and at 5, 30,
90, and 180 min during reperfusion. At the same time points,
MCE was performed with intravenous infusion of AF0150 (4
mg/min). Gated end-systolic images in short axis were acquired in
harmonic mode and digitized on-line. Background-subtracted
videointensity measured from MCE and RBF obtained from
fluorescent microspheres were calculated for the risk area and for
a control area, and were expressed as the ratio of the two areas.
Results. After initial hyperemia, a progressive reduction in flow
was observed during reperfusion. MCE correctly detected the time
course of changes in flow during occlusion-reperfusion. Videoin-
tensity ratio significantly correlated with RBF data (r 5 0.79; p <
0.0001).
Conclusions. The progressive reduction in blood flow occurring
within the postischemic microcirculation was accurately detected
by MCE. This approach has potential application in the evalua-
tion and management of postischemic reperfusion in humans.
(J Am Coll Cardiol 1998;32:1096–101)
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The prompt reopening of the infarct-related artery is the major
goal of the therapy of acute myocardial infarction. However,
after prolonged myocardial ischemia, the microvascular net-
work can be functionally and/or structurally damaged, and
reopening an epicardial vessel may not be followed by ade-
quate myocardial reperfusion, a condition referred to as “no-
or low-reflow” phenomenon (1–4). The microvascular damage
may be aggravated by reperfusion itself, a condition referred to
as reperfusion injury (5–7). As a result of the evolving func-
tional and structural microvascular damage, dynamic changes
in the degree of reflow may occur within the postischemic
microcirculation (6–10).
In the setting of reperfused myocardial infarction, the
extent of microvascular perfusion has been shown to predict
the ultimate amount of myocardial damage and the extent of
residual viability (11–15). Also, therapeutic interventions may
be developed that have the potential to control or limit deleteri-
ous changes observed after postischemic reflow (16). Therefore, it
would be important to have a method to detect and quantify
myocardial microvascular flow and to follow it over time.
Myocardial contrast echocardiography (MCE) has many
advantages as a technique to study the coronary microvascu-
lature in vivo (17). Recently, several microbubbles have been
created that, after venous injection, are able to transit the
pulmonary circulation in sufficient number to opacify both the
left ventricular (LV) cavity and the myocardial capillary bed
(18,19). Therefore, the present study was designed to define
the ability of MCE to assess microcirculatory perfusion during
reflow after acute coronary occlusion.
Methods
Animal preparation. Sixteen open-chest mongrel dogs
were subjected to either 90 or 180 min of coronary occlusion to
produce infarct size of variable extent. Reperfusion was
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achieved in all animals and maintained for 180 min. The
animal studies were performed in accordance with the “Posi-
tion of the American Heart Association on Research Animal
Use.”
The dogs were anesthetized (0.1–2.5 mg/kg of Propofol 1%;
Zeneca Pharm.), intubated, and ventilated with a respiratory
pump (model 55-0715; Harvard Apparatus). Additional anes-
thetic was administered as required. Body temperature was
kept within physiologic limits by adjusting a heating blanket.
The ECG was monitored continuously. Three 7F catheters
were placed: left femoral artery for withdrawal of reference
samples for blood flow measurements, right femoral artery to
record arterial pressure, and left femoral vein to infuse drugs
and fluids. A catheter (Swan-Ganz) monitored pulmonary
artery pressures and measured cardiac output. A high-fidelity
micromanometer-tipped LV catheter transducer recorded LV
pressure. A lateral thoracotomy was performed and the heart
was suspended in a pericardial cradle. A 7F silastic catheter
was placed in the left atrium for injection of fluorescent
microspheres. The proximal-mid part of the left anterior
descending (LAD) was dissected free from surrounding tissue
and an occluder was placed around it. An ultrasonic transit-
time flow probe (2.0–2.5 mm) was placed proximal to the
occluder and was connected to a flow meter (model T108;
Transonic System Inc.) for digital measurement of flow.
Myocardial contrast echocardiography. Echocardiography
was performed with a phased-array broad band 3–2–MHz
transducer (HDI3000; ATL). Images were obtained by placing
the transducer on a standoff consisting of a saline-filled latex
bag positioned on the epicardium of the LV anterior wall. The
transducer was maneuvered to yield a short axis view at the
midpapillary muscle level and was subsequently fixed in place
by a mechanical arm. The tomographic plane encompassing
the LAD perfusion territory distal to the occluder was identi-
fied by the appearance of wall motion abnormalities produced
by temporary coronary occlusion. Instrument settings were
optimized during contrast administration, and were subse-
quently held constant. Echocardiographic imaging was per-
formed using harmonic technology with ultrasound transmit-
ted at 1.67 and received at 3.33 MHz. A dynamic range of 60
dB and a mechanical index of 0.9 were used, and ECG-
triggered images were obtained at end-systole every six heart
beats.
AF0150 (Imagent US; Alliance Pharmaceutical Corp), a
perfluorochemical-stabilized contrast agent, was infused intra-
venously. A 100-mg vial of AF0150 was reconstituted with
10 mL saline solution, then diluted in 40 mL of saline. Upon
reconstitution, the agent yields a dispersion of surfactant-
coated, perfluorohexane/nitrogen-containing microbubbles.
The median diameter of these microbubbles is approximately
5 mm. Myocardial enhancement was achieved by a continuous
infusion of 4 mg/min, and images were obtained during
infusion after myocardial videointensity had reached a plateau.
Data were recorded on S-VHS videotape with a high-
fidelity video recorder and also acquired in a digital format
on-line using the Integrated Stress Echo Module (Nova Mi-
crosonics). The digital short axis views were analyzed using the
NIH Image 1.62 software package to delineate the endocardial
and epicardial borders, excluding the bright edge reflectors.
Custom-designed software (V.B. and K.O.) was then used to
obtain videointensity measurements from the myocardium
(0–255 gray levels). The risk area was identified as the
transmural area of absent contrast enhancement observed
after injection of contrast during coronary occlusion. At each
protocol data point, background-subtracted videointensity was
calculated for the risk area and for an adjacent control
myocardial zone in the perfusion territory of the circumflex
(LCx). Care was taken to limit the control zone so as to exclude
areas of signal attenuation and/or artifacts (Fig. 1). Videoin-
tensity measurements were expressed as the ratio of the
average intensity in the risk area to the average intensity in the
control zone. In this way, we eliminated the effects of attenu-
ation and other technical factors, as well as variations from
injection to injection and from animal to animal, which could
have influenced the results. At each data collection point,
percent regional myocardial thickening was calculated from
the center of the risk area using the formula: [(systolic
Abbreviations and Acronyms
LAD 5 left anterior descending artery
LCx 5 left circumflex artery
LV 5 left ventricular
MCE 5 myocardial contrast echocardiography
RBF 5 regional blood flow
Figure 1. Example is shown of a MCE study and the corresponding
anatomic myocardial slice. a, The LV short axis recorded at baseline
during the infusion of AF0150 and ECG-gated harmonic imaging. b,
During coronary occlusion, the LAD risk area was delineated by MCE
as an area of absent videointensity (solid outline) and, d, corresponded
to the anatomic risk area defined by the unstained area at Monastral
blue dye. b, The control area in the circumflex perfusion territory is
outlined in dots. c, After 3 h of reperfusion, the videointensity within
the risk area decreased relative to its baseline value.
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thickness 2 diastolic thickness)/diastolic thickness]z100, and
expressed as the percentage of the baseline value.
Myocardial blood flow measurement. Myocardial blood
flow was measured by standard techniques (20). Briefly, ap-
proximately, 3 3 106 15-mm fluorescent microspheres (Nuflow
Spheres; Triton Technology Inc.) were injected directly into
the left atrium. Reference blood samples were simultaneously
withdrawn from the femoral artery with a constant rate pump
(Harvard ‘33’ syringe pump) at a withdrawal rate of 15
mL/min. After the animal was euthanized, the heart was
explanted and sliced, and the cross-sectional slice of the LV
corresponding to the echo short-axis image was cut into 12
wedge-shaped transmural tissue samples for blood flow anal-
ysis. The tissue and the arterial reference samples were
processed using a flow cytometer to count the microspheres.
The value of RBF was derived for the risk area and for the
control zone, and their ratio (risk area/control) was calculated.
Determination of perfusion defect, risk area, and infarct
size. After the completion of the experimental protocol, the
risk area was delineated by reoccluding the LAD and injecting
a 1 mg/kg bolus of Monastral blue dye into the left atrium. The
dog was euthanized and the heart was explanted. The right
ventricle and the atria were removed and the left ventricle cut
into six slices parallel to the atrioventricular groove. The
myocardial slice corresponding to the echo short axis image
was incubated in a 2% solution of 2,3,5-triphenyltetrazolium
chloride (TTC) for 20 min at 37°C, and the infarct was
identified as the region that failed to demonstrate brisk red
staining. The LV slice was then photographed in color and the
outlines of the entire slice, the risk area, and the infarct size
were traced on transparencies and their area calculated by
digital planimetry (NIH Image 1.62).
Experimental protocol. For each animal, hemodynamics,
RBF and MCE data were acquired at baseline, at the end of
the occlusion period, and during four time points during
reperfusion (5, 30, 90, and 180 min). After the collection of the
last data point, the heart was sliced and processed for mea-
surements of risk area, infarct size, and RBF.
Statistical methods. Data from all animals were expressed
as mean 6 SEM. Correlation between MCE and RBF data was
performed by linear regression analysis. Comparisons of he-
modynamics, RBF, and MCE data were performed using
repeated-measures ANOVA, and Bonferroni t test was used to
assess the statistical difference between multiple comparisons.
A value of p , 0.05 (two-sided) was considered statistically
significant.
Results
All 16 animals completed the study protocol and technically
adequate images were obtained from each experiment. Hemo-
dynamic data for the entire study group are presented in Table
1. The hemodynamic changes observed were attributed to the
open-chest model of prolonged coronary occlusion and reper-
fusion (21). During coronary occlusion, regional myocardial
thickening of the risk area was significantly reduced to 20% of
the baseline value. During reperfusion, regional myocardial
thickening progressively decreased until it was nearly absent
after 30 min of reflow (Table 1).
The risk area of the study population was 43 6 4% of the
left ventricle, and the infarct size was 28 6 4% of the risk area.
Figure 1d shows an example of the definition of risk area by
blue dye and infarct size by TTC staining.
Temporal changes of regional myocardial blood flow. Myo-
cardial blood flow exhibited dynamic changes during this
protocol (Fig. 2). At baseline, RBF within the risk area was
comparable with that of the control zone (risk area/control
ratio 5 0.92 6 0.02). During coronary occlusion, RBF ratio
was significantly reduced from baseline (p , 0.0001). Five
minutes after coronary artery reopening, a significant hyper-
emic response was observed within the risk area with conse-
quent increase in RBF ratio (p , 0.0001 vs. baseline). After
30 min of reperfusion, RBF ratio returned to baseline values.
Blood flow within the risk area was then progressively reduced
over time and RBF ratio reached a value lower than baseline
at 90 min of reflow (p , 0.0001 vs. baseline) with further
reduction at 180 min of reperfusion (Fig. 2). Thus, RBF ratio
was characterized by a decrease with occlusion, an increase
immediately after reperfusion, and a subsequent fall after
90 min of reflow with further reduction at 180 min to levels
below those of baseline.
Myocardial contrast echocardiography. Videointensity
values also varied during the protocol in a pattern identical to
that of RBF (Fig. 2). At baseline, similar videointensity in the
Table 1. Hemodynamic Data
Baseline Occlusion Rep 5 min Rep 30 min Rep 90 min Rep 3 h
Heart rate (beats/min) 124.2 6 3.7 120.1 6 4.38 112. 6 6.3 104.7 6 3.8* 99.7 6 4* 100.8 6 4.4*
Mean Pulm P (mm Hg) 16.5 6 0.7 19 6 1* 21.1 6 1* 20.4 6 0.9* 20 6 1.2* 20.2 6 1*
Wedge P (mm Hg) 6.3 6 0.7 7.37 6 0.8 8 6 0.8 7.7 6 0.5 7.2 6 0.4 7.3 6 0.4
Mean Art P (mm Hg) 106.2 6 4.8 96.4 6 5 80.2 6 3.8* 76 6 3.2* 65.1 6 3.7* 63.8 6 4.5*
LV P (mm Hg) 115.2 6 5.1 101.4 6 5.5† 87.4 6 4.9* 84.8 6 3.2* 76.6 6 3.2* 84 6 4.3*
LVedp (mm Hg) 4.7 6 0.6 6.5 6 1 6.7 6 0.9 7.3 6 0.9 7.9 6 1.3* 7.5 6 1.4†
CO (l/min) 3 6 0.2 2.2 6 0.1* 2.1 6 0.2* 1.9 6 0.1* 1.79 6 0.1* 1.8 6 0.1*
Thickening (%) 100 17.6 6 17.6* 9.7 6 10.3* 21.0 6 8.4* 0.4 6 7.4* 3 6 10.8*
*p , 0.005 vs. baseline; †p , 0.05 vs. baseline. Art 5 arterial; CO 5 cardiac output; edp 5 end-diastolic pressure; P 5 pressure; Pulm 5 pulmonary; Rep 5
reperfusion.
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risk area and control zone support our visual observation of
uniform myocardial opacification of the LV short axis (Fig.
1a). During coronary occlusion, a minimal contrast effect
detected in the risk area was interpreted as noise or as
reflecting the presence of intramyocardial collateral flow. The
videointensity ratio increased above baseline 5 min after
reopening the vessel, then returned to baseline in the first
30 min of reperfusion and subsequently manifested a small
progressive decline throughout reperfusion in a fashion similar
to that seen with RBF (Fig. 2). Figure 3 shows a series of
ultrasound images acquired during a representative MCE
study.
At each time point during occlusion and reperfusion,
measurements of videointensity ratio showed a good correla-
tion with those of flow (MCE 5 0.07 1 0.91 3 RBF; r 5 0.79;
p , 0.0001), as shown in Figure 4.
Discussion
This study delineated a pattern of microvascular perfusion
during postischemic reflow characterized by an immediate
hyperemic response followed by a prompt return toward
baseline and then a progressive reduction of flow. MCE
performed with intravenous AF0150 and ECG-gated harmonic
imaging consistently delineated this pattern and yielded values
for reperfusion flow that correlated closely with those deter-
mined by microspheres. Thus, these data provide the basis for
an important role for MCE in the assessment of reperfusion
microcirculatory flow.
Time course of postischemic microvascular perfusion. Re-
gional microvascular perfusion after coronary reflow reflects
the status of the microvasculature. A prolonged, but reversible,
ischemic injury produces functional and structural abnormali-
ties of both the myocardium and the microvasculature. If the
patency of the epicardial vessel is restored after 90 min of
ischemia, blood flow within the myocardium may be partially
or totally absent in areas of damaged and obstructed micro-
vasculature (6). Such no- or low-reflow areas have been
demonstrated to show little improvement of regional and
global myocardial function at follow-up and a higher incidence
Figure 2. This graph displays the changes over time of risk area/
control area ratios of videointensity obtained from MCE and RBF in
this study. Values are reported at baseline (BSL), during LAD
occlusion (OCC), and at 5, 30, 90, and 180 min of reperfusion (RP).
Both MCE and RBF ratios follow the same trend and their values are
identical at each time point. Both parameters decreased significantly
during coronary occlusion and increased over baseline at 5 min of
reperfusion (*p , 0.0001 vs. baseline). At 30 min of reperfusion, both
MCE and RBF ratios returned to baseline values and then progres-
sively decreased at 90 and 180 min of reperfusion to a level lower than
baseline (*p , 0.0001 vs. baseline for RBF).
Figure 3. This figure shows a representative MCE case
demonstrating the progressive changes in videointensity
observed within the risk area during coronary occlusion and
reperfusion. a, The contrast-enhanced LV short axis at
baseline. The infusion of the contrast agent and the ECG-
gated harmonic imaging yielded uniform myocardial opaci-
fication with no attenuation of the posterior wall. b, The risk
area is delineated by absent contrast enhancement during
LAD occlusion (between arrows). c, Five min after the
release of the coronary occlusion, an increase in videointen-
sity is noted within the postischemic myocardium, which
correlated with the hyperemic flow detected by micro-
spheres. d, e, and f, The MCE images acquired at 30, 90, and
180 min of reperfusion, respectively. A clear progressive
reduction in videointensity can be observed within the risk
area.
Figure 4. Linear correlation between MCE ratio and RBF ratio for all
the data points in this study.
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of adverse clinical events (11,12,22). Furthermore, even though
reestablishing flow after prolonged ischemia can reduce the
infarct size, it might also be responsible for additional myocar-
dial and microvascular damage to that induced by the ischemia
(5–7).
Reperfusion is a dynamic phenomenon, characterized by
serial changes in flow in the postischemic microcirculation. The
precise time-course of changes in reflow remains controversial.
A study by Ambrosio et al. (6) reported the time-course of
postischemic reflow in a canine model of 90 min of reversible
coronary occlusion. After an initial hyperemic phase (2 min
after reflow), RBF was progressively reduced over the 210-min
period of observation. However, another report (23), which
studied 3 h of reversible coronary occlusion in canines, could
not demonstrate a clear trend toward flow reduction within the
risk area over 3 h of reperfusion. The reason for this discrep-
ancy is uncertain; it has been suggested to be related to the
different duration of occlusion. However, data in our study
demonstrated that after 180 min of coronary occlusion, myo-
cardial blood flow and videointensity had a trend in progressive
reduction during reperfusion similar to that observed after
90 min of occlusion. Moreover, after the longer coronary
occlusion, we observed lower flow and videointensity values
throughout reperfusion. Thus, the current data support the
existence of a progressive reduction of microvascular reperfu-
sion after transient coronary occlusion.
Myocardial contrast echo in the evaluation of postischemic
reperfusion. MCE has unique potential for the in vivo assess-
ment of the amount and spatial distribution of microvascular
patency, myocardial blood flow, and volume (17,24–26). If
properly engineered, gas microbubbles injected into the blood
stream can flow freely within the microvasculature with a
rheologic behavior similar to that of red blood cells (27).
Ultrasound can detect passage of these microbubbles within
the microcirculation and display an image with information on
the location and concentration of bubbles within the myocar-
dium that reflects the topographic distribution and density of
patent coronary microvessels (24).
In humans, all the currently available information regarding
postischemic reperfusion derives from MCE studies in which
microbubble agents have been injected directly into the coro-
nary circulation (11–15). Recent improvements in engineering
of the bubbles have resulted in a new generation of contrast
agents suitable for the study of myocardial perfusion during
intravenous administration (18,19). Early experimental studies
in animals have demonstrated that MCE obtained with intra-
venous infusion of perfluorocarbon-based contrast agents can
accurately define myocardial area at risk during coronary
occlusion and infarct size during reperfusion (28). The current
data expand these potential applications to include the deter-
mination of postocclusion microcirculatory flow.
In this study, we elected to use harmonic imaging as
opposed to fundamental imaging. The superior efficacy of
harmonic methods in bubble detection and quantitation over
fundamental mode has been demonstrated (29,30). In addi-
tion, to avoid attenuation of far field signals and saturation of
the instrument due to high concentration of bubbles, only a
small dose of the contrast agent was administered in the form
of a continuous infusion. The detection of the small number of
resonant bubbles injected was amplified by delivering the
ultrasound energy gated to the ECG in order to limit their
dissolution (31).
Limitations of the study. In this study we used the video-
intensity of the contrast effect within the myocardium as an
estimate of myocardial blood flow. Although it has been shown
that peak myocardial videointensity is primarily related to
myocardial blood volume (32), changes in myocardial blood
volume can be reflected via changes in flow. We observed a
close relationship between myocardial videointensity and RBF,
suggesting that the changes in flow observed were coupled with
alterations of blood volume. Moreover, it is known that
videointensity loses its linear relationship with flow at high flow
values (32). Therefore, we were careful to adjust the instru-
ment settings and select the contrast dose in order to remain
within the linear range of videointensity and flow during the
entire experiment. Also we measured the ratio of videointen-
sity between two beds (LAD and LCx), which obviated the
need for a strict linear relation between microbubble concen-
tration and flow, since the relative changes in bubble concen-
tration were compared with the corresponding changes in
microsphere blood flow.
Only one triggering interval (once every six beats) was used
in this study, and was selected since it appeared to achieve
optimal, uniform myocardial opacification at the dose of
contrast and machine settings used. Other intervals, especially
in conjunction with other agents, may yield different results.
Also, we used only a single contrast agent in this study, whose
advantages and limitations compared with other agents cannot
be defined by our protocol.
We did not attempt to unmask any possible abnormalities
of the vasodilatory reserve of the coronary microcirculation. It
is well known that impairment of this reserve is the earliest
change induced by the ischemic injury (9,33), and MCE has
been demonstrated to reliably detect this abnormality (23).
Therefore, it is conceivable that if a vasodilator had been used
in this study, myocardial blood flow and contrast videointensity
would have been further impaired at each stage of reperfusion
relative to the control area. However, examination of micro-
vascular flow reserve was not one of the aims of this study. In
addition, the value of assessing flow reserve in the clinical
practice remains to be determined. Additional studies specif-
ically designed to address this issue are needed.
The coronary occlusion produced in this study was com-
pletely and instantaneously reversed. A longer delay before
reperfusion or persistence of a residual stenosis, such as often
occurs with thrombolysis in the clinical arena, may theoreti-
cally change the time-course and the amount of myocardial
reflow. The presence of multivessel disease might also influ-
ence the results obtained. The role of these variables remains
to be investigated.
Clinical implications. The results of this experimental
study have potential clinical implications. Reopening of the
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infarct-related vessel is currently attempted in the majority of
patients with acute myocardial infarction in order to reestab-
lish flow to the myocardium and limit infarct size. However,
the efficacy of recanalization therapy in achieving reperfusion
at the level of postischemic myocardium cannot be assumed
from the successful reopening of the epicardial vessel. Absence
of microvasculature integrity after acute myocardial infarction
implicates more extensive necrosis and greater functional
impairment, as shown by more pronounced cardiac enzyme
elevation and more severe regional contractility deterioration
(11–15). Because of the functional importance of the micro-
vasculature during ischemia-reperfusion, the variable severity
of impairment during reperfusion, and because of the recently
demonstrated ability of calcium antagonists to limit microvas-
cular dysfunction after acute infarction (16), serial evaluation
of both the extent and severity of microvascular impairment is
of great clinical importance both in the acute and subacute
phase of infarction. Our data establish that MCE has the
potential to yield such information.
We are particularly grateful to Barry Peters, MD, Jim Reynolds, and Jessica
Weigenseil for their valuable technical support during the study protocol, and to
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